Last reviewed · How we verify
NCT03690518: QUALIREHAB
Rehabilitation of Adolescents and Young Adults With Congenital Heart Diseases
NA trial testing Cardiac rehabilitation in Heart Defects, Congenital in 142 participants. Completed in 12 September 2022.
12 September 2022
Quick facts
| Lead sponsor | University Hospital, Montpellier |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 142 |
| Start date | 27 July 2018 |
| Primary completion | 12 September 2022 |
| Estimated completion | 12 September 2022 |
| Sites | 17 locations across France |
Drugs / interventions tested
- Cardiac rehabilitation
Conditions studied
- Heart Defects, Congenital — all drugs for Heart Defects, Congenital →
- Adolescent — all drugs for Adolescent →
- Young Adult — all drugs for Young Adult →
Sponsor
University Hospital, Montpellier
Who can join
Adults 13 to 25, any sex, with Heart Defects, Congenital or Adolescent. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim to measure the impact of a rehabilitation program in congenital cardiology in terms of health related quality of life. The orginality of the rehabilitation program consists in its design : initial hospitalizationfor a short period of time (5 days) at the rehabilitation center, followed by 11 weeks of rehabilitation at home under the supervision of a specialized sports trainer.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
The molecular mechanisms of cardiac development and related diseases.
Li Y, Du J, Deng S, Liu B, et al · · 2024 · cited 53× · PMID 39715759 · DOI 10.1038/s41392-024-02069-8 -
Physical activity interventions for people with congenital heart disease.
Williams CA, Wadey C, Pieles G, Stuart G, et al · · 2020 · cited 40× · PMID 33112424 · DOI 10.1002/14651858.cd013400.pub2 -
Impact of a centre and home-based cardiac rehabilitation program on the quality of life of teenagers and young adults with congenital heart disease: The QUALI-REHAB study rationale, design and methods.
Amedro P, Gavotto A, Legendre A, Lavastre K, et al · · 2019 · cited 39× · PMID 30616811 · DOI 10.1016/j.ijcard.2018.12.050 -
Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial.
Amedro P, Gavotto A, Huguet H, Souilla L, et al · · 2024 · cited 24× · PMID 38430485 · DOI 10.1093/eurheartj/ehae085 -
Impact of COVID-19 disease on clinical research in pediatric and congenital cardiology.
Pommier V, Abassi H, Lavastre K, Calderon J, et al · · 2022 · cited 3× · PMID 35523633 · DOI 10.1016/j.arcped.2022.03.004
Verify or expand the search:
- PubMed search for NCT03690518
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cardiac rehabilitation
Trials testing the same drug.
- NCT06867926 — The Effect of Cardiac Rehabilitation on Oxidative DNA Damage and Inflammation in Patients With Coronary Artery Disease · NA · recruiting
- NCT06896318 — Virtual Reality-Supported Cardiac Rehabilitation: Psychological, Functional, and Physiological Perspectives · NA · active not recruiting
- NCT07205393 — Phase One Cardiac Rehabilitation Outcomes Post Valve Replacement Surgery · NA · recruiting
- NCT07019506 — Evaluation of the Effectiveness of Physical Exercise on Aerobic Capacity in Patients With Cardiovascular Disease · recruiting
- NCT06211361 — Cardiac Rehabilitation Program in Patients with Cardiovascular Disease · NA · active not recruiting
Other recruiting trials for Heart Defects, Congenital
Currently open trials in the same condition.
- NCT06003023 — Congenital Heart Disease Physical Activity Lifestyle Study V.2 · NA · recruiting
- NCT05709470 — Mind the Heart - Mental Health in Children and Adolescents With Congenital Heart Defects · recruiting
- NCT05330338 — Genetics of Ventriculo-arterial Discordance · NA · active not recruiting
- NCT06089902 — European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries · recruiting
Other University Hospital, Montpellier trials
Trials by the same sponsor.
- NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
- NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
- NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03690518 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
- Last refreshed: 31 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03690518.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing